Status: Not yet recruiting
Long-Term Follow-Up Study of Gamgertamig
This study will follow adults who previously received gamgertamig in another clinical study to evaluate long-term safety and clinical outcomes.
Participants needed: 100
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Lakefront Biotherapeutics West LLCUpdated: Sep 29, 2026
Eligibility criteria
Completed the protocol-defined treatment regimen in an eligible parent gamgertam... [+2]
Not applicable.